Skip to main content
Premium Trial:

Request an Annual Quote

New Biocomputing Center at Stanford Could Benefit Genome Project

Premium

PALO ALTO, Calif.--The Stanford University School of Medicine here is building a national biocomputational center through a partnership with NASA that could benefit the Human Genome Project, officials said. Although the primary use of the center will be to study the use of virtual reality in medicine, it will be made available for other uses, including the Human Genome Project, according to Murial Ross, a NASA neuroscientist and director of the agency's Biocomputational Center in Moffet Field, Calif.

"NASA has the capability to analyze huge amounts of data," she said, explaining how the center could benefit the project by crunching raw data. Stephen Schendel, the new center's director, said it could be operational by year's end and added that he is looking to hire a couple of computer programmers with graphics experience to work at the center, he noted. NASA is funding the still-unnamed Stanford center with $500,000 annually for the next five years.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.